Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Juliane Strietz"'
Autor:
Anh Thu Dang, Juliane Strietz, Alessandro Zenobi, Hanif J. Khameneh, Simon M. Brandl, Laura Lozza, Gregor Conradt, Stefan H.E. Kaufmann, Walter Reith, Ivo Kwee, Susana Minguet, Sonia T. Chelbi, Greta Guarda
Publikováno v:
iScience, Vol 24, Iss 1, Pp 101900- (2021)
Summary: BTN3A molecules—BTN3A1 in particular—emerged as important mediators of Vγ9Vδ2 T cell activation by phosphoantigens. These metabolites can originate from infections, e.g. with Mycobacterium tuberculosis, or by alterations in cellular me
Externí odkaz:
https://doaj.org/article/de729f8b994f4debb0363e2537507785
Autor:
Juliane Strietz, Stella S. Stepputtis, Marie Follo, Peter Bronsert, Elmar Stickeler, Jochen Maurer
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 4, p 1808 (2021)
Triple-negative breast cancer (TNBC) is one of the most aggressive subtypes of breast cancer, with only limited treatment options available. Recently, cancer stem cells (CSCs) have emerged as the potential drivers of tumor progression due to their ab
Externí odkaz:
https://doaj.org/article/9767df52dc3847ff889757dfb1653387
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 2, p 404 (2020)
Triple-negative breast cancer (TNBC) is a subtype of breast cancer characterized by the absence of estrogen and progesterone receptors (ER, PR) and lacking an overexpression of human epidermal growth factor receptor 2 (HER2). Apart from this lack of
Externí odkaz:
https://doaj.org/article/924e83a182d9427b86d437e619656204
Autor:
Katrin Raute, Juliane Strietz, Maria Alejandra Parigiani, Geoffroy Andrieux, Oliver S. Thomas, Klaus M. Kistner, Marina Zintchenko, Peter Aichele, Maike Hofmann, Houjiang Zhou, Wilfried Weber, Melanie Boerries, Mahima Swamy, Jochen Maurer, Susana Minguet
Publikováno v:
Cancer Immunology Research. :OF1-OF20
There are no targeted therapies for patients with triple-negative breast cancer (TNBC). TNBC is enriched in breast cancer stem cells (BCSC), which play a key role in metastasis, chemoresistance, relapse, and mortality. γδ T cells hold great potenti
Autor:
Susana Minguet, Jochen Maurer, Mahima Swamy, Melanie Boerries, Wilfried Weber, Houjiang Zhou, Maike Hofmann, Peter Aichele, Marina Zintchenko, Klaus M. Kistner, Oliver S. Thomas, Geoffroy Andrieux, Maria Alejandra Parigiani, Juliane Strietz, Katrin Raute
Supplementary Video S1 UT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c266542d20b9653517c320c8a2e73ca
https://doi.org/10.1158/2326-6066.22758530.v1
https://doi.org/10.1158/2326-6066.22758530.v1
Autor:
Susana Minguet, Jochen Maurer, Mahima Swamy, Melanie Boerries, Wilfried Weber, Houjiang Zhou, Maike Hofmann, Peter Aichele, Marina Zintchenko, Klaus M. Kistner, Oliver S. Thomas, Geoffroy Andrieux, Maria Alejandra Parigiani, Juliane Strietz, Katrin Raute
Supplementary Video S2 MMP14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1df7fc30f9af814bb6076c0ff4f8fd74
https://doi.org/10.1158/2326-6066.22758527
https://doi.org/10.1158/2326-6066.22758527
Autor:
Susana Minguet, Jochen Maurer, Mahima Swamy, Melanie Boerries, Wilfried Weber, Houjiang Zhou, Maike Hofmann, Peter Aichele, Marina Zintchenko, Klaus M. Kistner, Oliver S. Thomas, Geoffroy Andrieux, Maria Alejandra Parigiani, Juliane Strietz, Katrin Raute
There are no targeted therapies for patients with triple-negative breast cancer (TNBC). TNBC is enriched in breast cancer stem cells (BCSC), which play a key role in metastasis, chemoresistance, relapse, and mortality. γδ T cells hold great potenti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::694833b100a920f63b9a4d625b9dde18
https://doi.org/10.1158/2326-6066.c.6629870
https://doi.org/10.1158/2326-6066.c.6629870
Autor:
Susana Minguet, Jochen Maurer, Mahima Swamy, Melanie Boerries, Wilfried Weber, Houjiang Zhou, Maike Hofmann, Peter Aichele, Marina Zintchenko, Klaus M. Kistner, Oliver S. Thomas, Geoffroy Andrieux, Maria Alejandra Parigiani, Juliane Strietz, Katrin Raute
Supplementary Table S1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa2adc15ef9cd63034bafc25e535a4d6
https://doi.org/10.1158/2326-6066.22758533
https://doi.org/10.1158/2326-6066.22758533
Autor:
Roland Schüle, Jochen Maurer, Toufike Kanouni, Jeffrey A. Stafford, Michael B. Wallace, Jiangchun Xu, Elmar Stickeler, Melanie Boerries, Marie Follo, Amelie Proske, Peter Bronsert, Nicola Iovino, Fides Zenk, Anita Allen, Dominica Willmann, Sylvia Urban, Bogdan-Tiberius Preca, Juliane Strietz, Stella S. Stepputtis, Eric Metzger
This file contains the legends to all Supplementary Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5761318b1f6435dcbf3e792e5a2fa818
https://doi.org/10.1158/0008-5472.22419060.v1
https://doi.org/10.1158/0008-5472.22419060.v1
Autor:
Roland Schüle, Jochen Maurer, Toufike Kanouni, Jeffrey A. Stafford, Michael B. Wallace, Jiangchun Xu, Elmar Stickeler, Melanie Boerries, Marie Follo, Amelie Proske, Peter Bronsert, Nicola Iovino, Fides Zenk, Anita Allen, Dominica Willmann, Sylvia Urban, Bogdan-Tiberius Preca, Juliane Strietz, Stella S. Stepputtis, Eric Metzger
H3K9me3 levels increase upon treatment with QC6352. Changes in H3K9me3 levels are depicted according to genomic location.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03971b883243e51d248ae86c72123875
https://doi.org/10.1158/0008-5472.22419069
https://doi.org/10.1158/0008-5472.22419069